Understand your health. Know what to ask.
Heart palpitations on a GLP-1: what needs attention
A small average heart-rate increase in trials does not explain every racing or irregular heartbeat. New palpitations need their own assessment.
4 sources · NIHRead · 2 min →
Dizziness when standing on a GLP-1: what it can mean
Standing-related dizziness can involve a blood-pressure drop, dehydration or another cause. Timing and related symptoms help guide the assessment.
4 sources · NIHRead · 2 min →
TSH and the GLP-1 thyroid warning answer different questions
TSH assesses thyroid function. It does not replace the personal and family history review required by semaglutide and tirzepatide warnings.
3 sources · NIHRead · 2 min →
Peptide certificates of analysis: what a COA can verify
A certificate of analysis reports specific batch tests. It does not establish that a research chemical is safe or effective for human use.
3 sources · FDARead · 2 min →
Compounded semaglutide: storage, labeling and sterility questions
What to clarify about a compounded semaglutide shipment, including the pharmacy, storage instructions and signs of a delivery problem.
3 sources · FDARead · 2 min →
Are peptides medicines or supplements? Read the product category
Peptide describes a molecule. Prescription drugs, compounded preparations, dietary supplements and research chemicals follow different rules.
5 sources · FDARead · 2 min →
GLP-1 treatment and a higher resting heart rate
Approved semaglutide labeling includes an increase in resting heart rate. Report sustained changes or a racing heartbeat at rest to the prescriber.
1 source · NIHRead · 2 min →
Hair shedding during weight loss: what gets checked
Weight change, illness, childbirth and other factors can precede shedding. The timing and scalp findings help distinguish the possibilities.
3 sources · NIHRead · 2 min →
What “research use only” means on a peptide vial
Research-use labeling does not establish suitability for human treatment. Product identity, approval status and the dispensing source are separate checks.
3 sources · FDARead · 2 min →
Comparing tirzepatide costs and continuity of care
What an advertised price leaves to clarify about billing, the supplied product and follow-up if an order or treatment changes.
3 sources · FDARead · 2 min →
Questions about how a compounded medication is prepared
How to ask a compounding pharmacy about product identity, handling and quality without confusing facility oversight with drug approval.
3 sources · FDARead · 2 min →
GLP-1 treatment and gallbladder warning signs
Persistent upper-right abdominal pain, fever or jaundice should not be dismissed as routine GLP-1 nausea. Learn why gallbladder symptoms need assessment.
3 sources · NIHRead · 2 min →